NEW YORK (GenomeWeb News) — Ciphergen has hired European international standards consulting company Emergo to help it win CE Mark clearance for its ovarian cancer in vitro diagnostic, the company said today.
The company said it also is preparing a clinical trial toward gaining clearance with the US Food and Drug Administration.